New Research Poster Presentation 3.30: Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Children and Adolescents (6–17 Years Old): Line-Item Analysis of the Aberrant Behavior Checklist Irritability Subscale

Thursday, October 29, 2009 12:30 PM

Michael G. Aman, Ph.D., Ohio State University, Columbus, OH

William Kasper, PharmD, Bristol-Myers Squibb Company, Plainsboro, NJ

George Manos, Ph.D., Bristol-Myers Squibb Company, Wallingford, CT

Raymond Mankoski, M.D., Ph.D., Bristol-Myers Squibb Company, Plainsboro, NJ

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

Suja Mathew, B.S., Otsuka America Pharmaceutical, Inc., Rockville, MD

Ronald Marcus, M.D., Bristol-Myers Squibb Company, Wallingford, CT

Randall Owen, M.D., Bristol-Myers Squibb Comopany, Wallingford, CT

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.30 Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Children and Adolescents (6–17 Years Old): Line-Item Analysis of the Aberrant Behavior Checklist Irritability Subscale